trial · primary record
Ruxolitinib
Polycythemia Vera
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 586 |
| Primary completion | 2030-04-01 |
| Primary endpoint | Event Free Survival (EFS) |
| Registry ID | NCT04116502 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:11.348Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04116502
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.